Molecularly Targeted Agents in the Therapy of Pediatric Brain Tumors
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecularly Targeted Agents in the Therapy of Pediatric Brain Tumors
Authors
Keywords
-
Journal
PEDIATRIC DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-21
DOI
10.1007/s40272-019-00369-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy
- (2019) Stephanie A. Toll et al. Oncotarget
- Medulloblastoma
- (2019) Paul A. Northcott et al. Nature Reviews Disease Primers
- A pilot precision medicine trial for children with diffuse intrinsic pontine glioma - PNOC003: a report from the Pacific Pediatric Neuro-Oncology Consortium
- (2019) Sabine Mueller et al. INTERNATIONAL JOURNAL OF CANCER
- Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
- (2019) Jason Fangusaro et al. LANCET ONCOLOGY
- Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies
- (2018) Jun Wang et al. Annual Review of Neuroscience
- The distribution, clearance, and brainstem toxicity of panobinostat administered by convection-enhanced delivery
- (2018) William G. B. Singleton et al. Journal of Neurosurgery-Pediatrics
- Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
- (2018) Theodore W Laetsch et al. LANCET ONCOLOGY
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non‐Small Cell Lung Cancers HarboringBRAF V600EMutations
- (2018) Lauretta Odogwu et al. ONCOLOGIST
- Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma
- (2018) David S. Ziegler et al. BRITISH JOURNAL OF CANCER
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
- (2018) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma
- (2018) Teresa Purzner et al. Science Signaling
- BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study
- (2018) Thomas Kaley et al. JOURNAL OF CLINICAL ONCOLOGY
- TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening
- (2018) Catherine M. Albert et al. JOURNAL OF CLINICAL ONCOLOGY
- The molecular landscape of glioma in patients with Neurofibromatosis 1
- (2018) Fulvio D’Angelo et al. NATURE MEDICINE
- Current therapy and the evolving molecular landscape of paediatric ependymoma
- (2017) Soumen Khatua et al. EUROPEAN JOURNAL OF CANCER
- Sustained Response to Targeted Therapy in a Patient With Disseminated Anaplastic Pleomorphic Xanthoastrocytoma
- (2017) Nisreen Amayiri et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Target and Agent Prioritization for the Children’s Oncology Group—National Cancer Institute Pediatric MATCH Trial
- (2017) Carl E. Allen et al. JNCI-Journal of the National Cancer Institute
- The whole-genome landscape of medulloblastoma subtypes
- (2017) Paul A. Northcott et al. NATURE
- A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
- (2017) Anuradha Banerjee et al. NEURO-ONCOLOGY
- Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations
- (2017) Anika Bongaarts et al. Oncotarget
- Target and Agent Prioritization for the Children’s Oncology Group—National Cancer Institute Pediatric MATCH Trial
- (2017) Carl E. Allen et al. JNCI-Journal of the National Cancer Institute
- Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models
- (2017) Tammy Hennika et al. PLoS One
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
- (2016) Michele Ceccarelli et al. CELL
- Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas
- (2016) Jie Zhang et al. JOURNAL OF NEURO-ONCOLOGY
- Recurrent MET fusion genes represent a drug target in pediatric glioblastoma
- (2016) NATURE MEDICINE
- Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy
- (2016) Cassie N. Kline et al. NEURO-ONCOLOGY
- Biology and management of ependymomas
- (2016) Jing Wu et al. NEURO-ONCOLOGY
- Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma
- (2016) Hamid Nikbakht et al. Nature Communications
- Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics
- (2016) Lindsey M. Hoffman et al. Acta Neuropathologica Communications
- Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
- (2015) David Castel et al. ACTA NEUROPATHOLOGICA
- Pilocytic astrocytoma: pathology, molecular mechanisms and markers
- (2015) V. Peter Collins et al. ACTA NEUROPATHOLOGICA
- Smoothened Inhibitors in Sonic Hedgehog Subgroup Medulloblastoma
- (2015) Katherine J. Ransohoff et al. JOURNAL OF CLINICAL ONCOLOGY
- BRAFMutation andCDKN2ADeletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma
- (2015) Matthew Mistry et al. JOURNAL OF CLINICAL ONCOLOGY
- Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape
- (2015) Amar Gajjar et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis
- (2015) Jonathon Torchia et al. LANCET ONCOLOGY
- Erratum: Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
- (2015) Catherine S Grasso et al. NATURE MEDICINE
- Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma
- (2015) E. Q. Lee et al. NEURO-ONCOLOGY
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- (2015) Cynthia Wetmore et al. NEURO-ONCOLOGY
- Epigenetic dysregulation: a novel pathway of oncogenesis in pediatric brain tumors
- (2014) Adam M. Fontebasso et al. ACTA NEUROPATHOLOGICA
- CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity
- (2014) Tara Spence et al. ACTA NEUROPATHOLOGICA
- SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis
- (2014) Martin Hasselblatt et al. ACTA NEUROPATHOLOGICA
- Pediatric low-grade gliomas: How modern biology reshapes the clinical field
- (2014) Guillaume Bergthold et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Chromosome Band 7q34 Deletions Resulting inKIAA1549-BRAFandFAM131B-BRAFFusions in Pediatric Low-Grade Gliomas
- (2014) Jacquelyn J. Roth et al. BRAIN PATHOLOGY
- Facing the Future of Brain Tumor Clinical Research
- (2014) M. R. Gilbert et al. CLINICAL CANCER RESEARCH
- Molecular Insights into Pediatric Brain Tumors Have the Potential to Transform Therapy
- (2014) A. Gajjar et al. CLINICAL CANCER RESEARCH
- The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
- (2014) Gang Wu et al. NATURE GENETICS
- Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth
- (2014) Aparna Kaul et al. NEURO-ONCOLOGY
- GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity
- (2014) A. Vartanian et al. NEURO-ONCOLOGY
- Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas
- (2014) M. A. Karajannis et al. NEURO-ONCOLOGY
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Are pediatric brain tumors on the rise in the USA? Significant incidence and survival findings from the SEER database analysis
- (2013) Swetal Patel et al. CHILDS NERVOUS SYSTEM
- New Strategies in Pediatric Gliomas: Molecular Advances in Pediatric Low-Grade Gliomas as a Model
- (2013) E. Raabe et al. CLINICAL CANCER RESEARCH
- Data and Safety Monitoring Boards
- (2013) Paul W. Armstrong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- New drugs for children and adolescents with cancer: the need for novel development pathways
- (2013) Gilles Vassal et al. LANCET ONCOLOGY
- Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
- (2013) David T W Jones et al. NATURE GENETICS
- Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
- (2013) NATURE GENETICS
- Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas
- (2013) A. J. Sievert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular subgroups of medulloblastoma
- (2012) Paul A Northcott et al. Expert Review of Neurotherapeutics
- Is double inactivation of the Nf1 gene responsible for the development of congenital pseudarthrosis of the tibia associated with NF1?
- (2012) Sang Min Lee et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells
- (2012) Irina Alimova et al. NEURO-ONCOLOGY
- A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low-grade glioma (LGG)
- (2012) Michal Yalon et al. PEDIATRIC BLOOD & CANCER
- Molecular subgroups of medulloblastoma: the current consensus
- (2011) Michael D. Taylor et al. ACTA NEUROPATHOLOGICA
- Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
- (2011) Genevieve Schindler et al. ACTA NEUROPATHOLOGICA
- Multidisciplinary management of childhood brain tumors: a review of outcomes, recent advances, and challenges
- (2011) Ian F. Pollack Journal of Neurosurgery-Pediatrics
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma
- (2010) Erika F. Rodriguez et al. ACTA NEUROPATHOLOGICA
- Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
- (2010) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- An Overview of the Optimal Planning, Design, and Conduct of Phase I Studies of New Therapeutics
- (2010) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- Long-term survivors of childhood central nervous system malignancies: The experience of the Childhood Cancer Survivor Study
- (2010) Gregory T. Armstrong EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Infant Brain Tumors: Incidence, Survival, and the Role of Radiation Based on Surveillance, Epidemiology, and End Results (SEER) Data
- (2010) Andrew J. Bishop et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
- (2010) Darcy A. Krueger et al. NEW ENGLAND JOURNAL OF MEDICINE
- EGFRvIII Deletion Mutations in Pediatric High-Grade Glioma and Response to Targeted Therapy in Pediatric Glioma Cell Lines
- (2009) D. A. Bax et al. CLINICAL CANCER RESEARCH
- MAPK pathway activation and the origins of pediatric low-grade astrocytomas
- (2009) Ruth G. Tatevossian et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Different molecular patterns in glioblastoma multiforme subtypes upon recurrence
- (2009) Ramon Martinez et al. JOURNAL OF NEURO-ONCOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Induction of Abnormal Proliferation by Nonmyelinating Schwann Cells Triggers Neurofibroma Formation
- (2008) Huarui Zheng et al. CANCER CELL
- BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
- (2008) Stefan Pfister et al. JOURNAL OF CLINICAL INVESTIGATION
- Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor
- (2008) Susan N. Chi et al. JOURNAL OF CLINICAL ONCOLOGY
- Frequent Gains at Chromosome 7q34 Involving BRAF in Pilocytic Astrocytoma
- (2008) Eli E. Bar et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search